CSL Limited (ASX: CSL) shareholders will have something to cheer about today as the company improved the dividend amount to be paid out.
In CSL's full-year results, the board declared a partially franked final dividend of US$1.18 per share.
While the amount was kept the same as the prior corresponding period, it is the equal-highest dividend announced.
Nonetheless, the CSL share price tanked to a low of $278.89 on the day as investors vented their frustration with the company's outlook.
Today, however, shares in the biotherapeutics giant have recovered to last trade at $299.61 apiece.
Let's take a look in more detail at exactly how much CSL will pay out to shareholders.
CSL updates its final dividend
If you decided to buy CSL shares and hold them before they went ex-dividend on 6 September, you'll be eligible for the upcoming dividend.
Previously, CSL notified the market that the US$1.18 dividend would be roughly equivalent to A$1.68 per share.
However, with the exchange rate fluctuating in favour of the Australian dollar against the greenback, you'll receive a little more than expected.
In its release this morning, CSL provided an update in regards to the equivalent amount stating shareholders will now receive $1.758 per share.
While it may not seem like a great deal, as it's around 7 cents higher, this could mean a couple of hundred dollars for investors with a large holding.
CSL is scheduled to distribute the dividend payment to shareholder accounts on 5 October.
CSL share price snapshot
With CSL shares notching up 7.5% since the FY 2022 results, investor momentum appears to be growing.
Currently, the company's share price is around 13% lower than its previous all-time high of $342.75 (20 February 2020).
CSL has a price-to-earnings (P/E) ratio of 41.67 and a market capitalisation of $144.45 billion.
